Women’s

Therapy Areas

OncoNews

OncoNews

Lung Icon

Lung Cancer

Uterus Icon

Women's Cancers

Bladder Icon

Urogenital

GI Icon

Gastro-intestinal

Hematology Icon

Hematology

Other Solid Tumor Icon

Other Tumors

Antibody Drug Conjugates in Breast Cancer (E-Learning)

Marcus Vetter, MD
Feb 16 2025
E-Learning, Women's Cancers

Breast Cancer Subtype Definitions (1/4)

} 9 min 03

watch now
Christian Kurzeder, MD
Feb 16 2025
E-Learning, Women's Cancers

Breast Cancer Treatment Guidelines (2/4)

} 7 min 27

watch now
Marcus Vetter, MD
Feb 16 2025
E-Learning, Women's Cancers

Trials With ADCs in Breast Cancer (3/4)

} 10 min 47

watch now
Christian Kurzeder, MD
Feb 16 2025
E-Learning, Women's Cancers

AE Management With ADCs in Breast (4/4)

} 9 min 06

watch now

Videos

Breast Cancer by Peter Dubsky
Dec 18 2024
Women's Cancers

Breast Cancer 2024 Review

} 1 h 32 min

watch now
ADCs by Alessandra Curioni
Nov 06 2024
Antibody Drug Conjugates

Antibody Drug Conjugates

} 1 h 39 min

watch now
GYNE Session by Apostolos Sarivalasis
Sep 26 2024
Women's Cancers

Gynecological Cancers

} 1 h 32 min

watch now
Breast Session by Jens Huober
Jul 02 2024
Women's Cancers

Breast Cancer (ASCO 2024)

} 1 h 34 min

watch now
HER2 Session by Ilaria Colombo
Apr 30 2024
Biomarkers

HER2 in Lung, GYNE & GI Cancers

} 1 h 34 min

watch now
Breast Session by Peter Dubsky
Dec 13 2023
Women's Cancers

Breast Cancer 2023 Review

} 1 h 31 min

watch now
ADC Session by Alfredo Addeo
Nov 01 2023
Antibody Drug Conjugates

ADC in Breast, GU & Lung

} 1 h 31 min

watch now
Breast Session by Nadia Harbeck
Jun 28 2023
Women's Cancers

Breast Cancer (ASCO 2023)

} 1 h 31 min

watch now
HER2 Session by Sabina Berezowska
Apr 19 2023
Biomarkers

HER2 in Breast, Lung & GI Cancers

} 1 h 38 min

watch now
BRCA Session by Berna Özdemir
Nov 02 2022
Biomarkers

BRCA Mutated Tumors

} 1 h 31 min

watch now

Articles

Christina Fotopoulou
Christina Fotopoulou
Feb 12 2025
Women's Cancers
Advanced Ovarian Cancer: In Search of the Ideal Strategy
EMA Approval
Intravenous Drip
Feb 03 2025
Lung Cancer, Women's Cancers
CHMP Recommends Approval of Three Promising Therapies in the EU
Apostolos Sarivalasis
Apostolos Sarivalasis
Jan 22 2025
Women's Cancers
New Perspectives In The Early And Late Stages Of Cervical Cancer
FDA Approval
Intravenous Drip
Jan 20 2025
Women's Cancers
FDA Approves Dato-DXd for Advanced HR-Positive, HER2-Negative Breast Cancer
Jens Huober
Jens Huober
Nov 25 2024
Women's Cancers
Highlights from ESMO: Advancements in Early-Stage Triple-Negative Breast Cancer Treatments
Jens Huober
Jens Huober
Sep 13 2024
Women's Cancers
HR+/HER2- Advanced Breast Cancer: Chemotherapy-Free Options For Various Subgroups
Konstantin Dedes
Konstantin Dedes
Sep 05 2024
Women's Cancers
Early Breast Cancer: New Findings Through Subgroup And Biomarker Analyses
Ilaria Colombo
Ilaria Colombo
Jul 19 2024
Women's Cancers
HER2-Expressing Gynecological Cancers: Catching Up on Targeted Approaches
EMA Approval
Intravenous Drip
Jul 12 2024
Urogenital, Women's Cancers
EU Recommends New Treatments for Endometrial and Urothelial Cancers
EMA Approval
Breast Cancer
Jun 20 2024
Women's Cancers
Capivasertib Plus Fulvestrant Gains EU Approval for Advanced Breast Cancer

UPCOMING

Join us for
our roundtable in
||
latest advances in
||
your questions on
||
new therapies for
||
practice changes in
||
your patient cases in

MPN

Gabriela Baerlocher

Hirslanden Clinic Zurich, Switzerland

Claire Harrison

Guy's and St. Thomas' NHS Foundation Trust, London, UK

Sara Meyer

Inselspital, University Hospital Bern, Switzerland

AGENDA

Managing PV and MF: Integrating interferons, immunotherapies and new JAK2 inhibitors

Sara Meyer

Clinical significance of genomic testing in MPN: When to test what and what does it really mean?

TBD

Update on the management of CML: Navigating through the available and upcoming treatment options

Gabriela Baerlocher

2 CME Points by

SWISS SOCIETY OF HEMATOLOGY
(SGH • SSH)

Join our host, Sara Meyer, for an insightful roundtable on the latest progress in the treatment of myeloproliferative neoplasms (MPNs). This interdisciplinary roundtable gathers renowned experts to discuss groundbreaking findings, offering an in-depth exploration of new innovative therapeutic approaches for myelofibrosis, polycythaemia vera and chronic myeloid leukemia. Don’t miss this opportunity to enhance your understanding, engage in the discussion, and uncover the pivotal developments transforming the treatment landscape of myeloproliferative neoplasms.

ADD THIS TO YOUR CALENDAR

Register here

Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.

First Time On OncoViews?

Get Registered Now